One particular challenge in vaccine progress is economic: Lots of the illnesses most demanding a vaccine, such as HIV, malaria and tuberculosis, exist principally in poor nations around the world. Pharmaceutical corporations and biotechnology firms have little incentive to acquire vaccines for these conditions since there is tiny profits potential.